News

GSK and Vir Biotechnology enter collaboration to find coronavirus solutions

The collaboration will use Vir’s proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies for Covid-19.

Read More

Apr 09, 2020

By : Team ABLE

Stempeutics partners Global Consortium of cell therapy companies seeking European Union funding to combat Coronavirus Infections in Europe

Stempeutics is also working closely with agencies in India for making these solutions available in India.

Read More

Apr 08, 2020

By : Team ABLE

Indian Immunologicals partners Griffith University to create COVID-19 antibody

IIL said it has assessed different choices being followed over the world, before focusing on live lessened COVID-19 antibody dependent on codon de-improvement innovation.

Read More

Apr 08, 2020

By : Team ABLE

EpiVax-GAIA Vaccine Foundation to make COVID-19 vaccine license free to developing countries

EpiVax has announced its partnership with GAIA Vaccine Foundation (GVF) to crowd-source funds for the project.

Read More

Apr 08, 2020

By : Team ABLE

Merck bags second U.S. patent for CRISPR gene-editing technology

Merck says it is the only provider with a patent covering the fusion of chromatin modulating peptides to CRISPR proteins.

Read More

Apr 08, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights